Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The evidence base sits with the molecules, not the platforms STEP studied semaglutide for weight management (NEJM 2021), SURMOUNT studied tirzepatide (NEJM 2022), and SURMOUNT-OSA looked at tirzepatide in obstructive sleep apnea (NEJM 2024)
doi: 10.3389/ftox.2025.1426132 Received 30 April 2024 Accepted 13 January 2025 Published 21 February 2025 Volume 7 - 2025 Edited by Stina Oredsson, Lund University, Sweden Reviewed by Robert Landsiedel, BASF, Germany Lan Ma-Hock, BASF, Germany Cynthia Bosquillon, University of Nottingham, United Kingdom Louis Scott, ImmuONE, United Kingdom Updates Copyright 2025 de vila, Mller, Barlow, Middleton, Theiventhran, Basili, Bowden, Saib, Engi, Pietrenko, Wallace, Boda, Constant, Behrsing, Patel and Baltazar
The PIONEER 4 randomized controlled trial was also included in the NMA, and therefore represented an option to inform the baseline cohort characteristics [24]
This guide will help you cover the basics of GLP-1 education while also providing you some alternative ideas to help your clients activate GLP-1 during or outside of medication usage
US$ 24.85
US$ 24.75
US$ 24.73
US$ 22.98
US$ 28.51
US$ 26.92
US$ 22.81
US$ 27.76
US$ 24.70
US$ 22.20
![Weepinbell (65/147) [Aquapolis] GG67](https://cdn.shopify.com/s/files/1/0876/8225/3078/files/5c5c050f-c65c-4360-b5e8-2528e77b9d45.png?v=1714708298)
